Description

Opzelura Ruxolitinib 1.5% Cream Pakistan – HealthnBeauty.Pk

Opzelura Ruxolitinib 1.5% Cream is a prescription topical medication containing ruxolitinib, a Janus kinase (JAK) inhibitor. It is used topically for specific inflammatory skin conditions, including mild-to-moderate atopic dermatitis and nonsegmental vitiligo, according to current U.S. prescribing information.

Key Features

• Contains ruxolitinib 1.5%
• Topical cream formulation
• Prescription medicine
• Indicated for nonsegmental vitiligo
• Approved for eligible adults and children aged 12+
• Supplied in 60 g and 100 g tubes according to the U.S. prescribing information

Key Ingredient

Ruxolitinib: A JAK inhibitor that works by interfering with signaling pathways involved in immune and inflammatory responses in the skin. Opzelura contains 1.5% ruxolitinib.

How Opzelura Is Used for Vitiligo

The current prescribing information recommends applying a thin layer twice daily to affected areas covering up to 10% of body surface area. Treatment should be used according to a healthcare professional’s instructions.